A Prospective, Single Arm, Multicenter, Phase II-Trial to Assess Safety and Efficacy of Preoperative RAdiation Therapy Before Radical CystEctomy Combined With ImmunoTherapy in Locally Advanced Urothelial Carcinoma of the Bladder
Phase of Trial: Phase II
Latest Information Update: 22 Feb 2019
Price : $35 *
At a glance
- Drugs Nivolumab (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- Acronyms RACE IT
- 05 Feb 2019 Status changed from not yet recruiting to recruiting.
- 17 Dec 2018 Planned initiation date changed from 1 Nov 2018 to 1 Jan 2019.
- 22 May 2018 New trial record